Approval · Notice of Compliance 34863 · 2025
RECOTHROM: Notice of Compliance 34863
Issued February 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34863
- Date
- February 17, 2025
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RECOTHROM | Not yet assigned | — |
Medicinal ingredients
- THROMBIN ALFA 6,000 UNIT per VIAL
- THROMBIN ALFA 24,000 UNIT per VIAL